» Articles » PMID: 29615880

Behavioral Characterization of β-Arrestin 1 Knockout Mice in Anxiety-Like and Alcohol Behaviors

Overview
Specialty Psychology
Date 2018 Apr 5
PMID 29615880
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

β-Arrestin 1 and 2 are highly expressed proteins involved in the desensitization of G protein-coupled receptor signaling which also regulate a variety of intracellular signaling pathways. Gene knockout (KO) studies suggest that the two isoforms are not homologous in their effects on baseline and drug-induced behavior; yet, the role of β-arrestin 1 in the central nervous system has been less investigated compared to β-arrestin 2. Here, we investigate how global β-arrestin 1 KO affects anxiety-like and alcohol-related behaviors in male and female C57BL/6 mice. We observed increased baseline locomotor activity in β-arrestin 1 KO animals compared with wild-type (WT) or heterozygous (HET) mice with a sex effect. KO male mice were less anxious in a light/dark transition test, although this effect may have been confounded by increased locomotor activity. No differences in sucrose intake were observed between genotypes or sexes. Female β-arrestin 1 KO mice consumed more 10% alcohol than HET females in a limited 4-h access, two-bottle choice, drinking-in-the-dark model. In a 20% alcohol binge-like access model, female KO animals consumed significantly more alcohol than HET and WT females. A significant sex effect was observed in both alcohol consumption models, with female mice consuming greater amounts of alcohol than males relative to body weight. Increased sensitivity to latency to loss of righting reflex (LORR) was observed in β-arrestin 1 KO mice although no differences were observed in duration of LORR. Overall, our efforts suggest that β-arrestin 1 may be protective against increased alcohol consumption in females and hyperactivity in both sexes.

Citing Articles

Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions.

Blaine A, Miao Y, Yuan J, Palant S, Liu R, Zhang Z Front Pharmacol. 2022; 13:914651.

PMID: 36059958 PMC: 9428791. DOI: 10.3389/fphar.2022.914651.


Phenotype Characterization of a Mice Genetic Model of Absolute Blindness.

Milla-Navarro S, Pazo-Gonzalez M, Germain F, de la Villa P Int J Mol Sci. 2022; 23(15).

PMID: 35897728 PMC: 9331777. DOI: 10.3390/ijms23158152.


An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects.

French A, van Rijn R Pharmacol Res. 2022; 177:106091.

PMID: 35101565 PMC: 8923989. DOI: 10.1016/j.phrs.2022.106091.


β-Arrestin-dependent ERK signaling reduces anxiety-like and conditioned fear-related behaviors in mice.

Ko M, Chiang T, Mukadam A, Mulia G, Gutridge A, Lin A Sci Signal. 2021; 14(694).

PMID: 34344831 PMC: 8497002. DOI: 10.1126/scisignal.aba0245.


G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder.

Gutridge A, Robins M, Cassell R, Uprety R, Mores K, Ko M Br J Pharmacol. 2019; 177(7):1497-1513.

PMID: 31705528 PMC: 7060366. DOI: 10.1111/bph.14913.


References
1.
Bohn L, Lefkowitz R, Gainetdinov R, Peppel K, Caron M, Lin F . Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science. 2000; 286(5449):2495-8. DOI: 10.1126/science.286.5449.2495. View

2.
Tian X, Kang D, Benovic J . β-arrestins and G protein-coupled receptor trafficking. Handb Exp Pharmacol. 2013; 219:173-86. PMC: 4513654. DOI: 10.1007/978-3-642-41199-1_9. View

3.
Conner D, Mathier M, Mortensen R, Christe M, Vatner S, Seidman C . beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ Res. 1997; 81(6):1021-6. DOI: 10.1161/01.res.81.6.1021. View

4.
Shi Y, Feng Y, Kang J, Liu C, Li Z, Li D . Critical regulation of CD4+ T cell survival and autoimmunity by beta-arrestin 1. Nat Immunol. 2007; 8(8):817-24. DOI: 10.1038/ni1489. View

5.
Ikeda M, Ozaki N, Suzuki T, Kitajima T, Yamanouchi Y, Kinoshita Y . Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes Brain Behav. 2007; 6(1):107-12. DOI: 10.1111/j.1601-183X.2006.00237.x. View